Bing

Amarin Corporation PLC:Says A U.S. judge on Friday barred the U.S. Food and Drug Administration from stopping Irish drugmaker Amarin Corp from promoting its fish oil drug for off-label uses, saying the company is protected by the First Amendment - …
Reuters · 8/7/2015
The company's shares dropped 20% to $9.60 in early trading Friday. The stock is down by more than a third in the past three months. The company is awaiting a decision from US officials on market exclusivity for the drug, a treatment that's more potent …
Minyanville · ByBrett Chase · 12/7/2012
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company s lead product includes Vascepa, a prescription-only omega-3 …
Yahoo Finance UK and Ireland · 8/24/2015
One of the S&P 500’s big losers for Monday August 03 was Pioneer Natural Resources Co. (PXD). The company’s stock fell 2.65% to $123.41 on volume of 2.44 million shares. The stock opened the day at 125.38 and traded between a low of $122.20 …
Equities · 8/3/2015
As many companies are releasing their second-quarter earnings reports, one investment firm has put out its list of top stock picks for the third quarter. David Kestenbaum, Morgan Joseph TriArtisan's head of equity research, detailed his firm's picks in an ...
CNBC · ByKatie Little · 7/23/2011
[PR Newswire] – ARMONK, N.Y., July 6, 2015 /PRNewswire/ — According to a paper published today in the journal Nature Nanotechnology, scientists discovered a phenomenon in which the use of carbon nanotubes, under specific conditions, could …
Jutia Group · 7/7/2015
Advancers are outpacing decliners 4 to 1 on the New York Stock Exchange Friday. Some 188 stocks hit new 52-week highs on the NYSE, while 28 hit new lows. Advancers are outpacing decliners 17 to 6 on the Nasdaq.
Market Watch Commentary · 7/27/2012

Amarin Corporation

Company
Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets me…
Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Amarin develops the drug Vascepa which is a prescription grade omega-3 fatty acid. In December 2007, the company acquired Ester Neurosciences Limited for 8.1 million USD. Amarin CEO Joe Zakrzewski has said that the company would like to first work on building its infrastructure out to commercialize the drug in the United States. Recently on July 26, 2012, their lead-candidate drug named Vascepa received FDA-approval. Vascepa will also be a key competitor against GlaxoSmithKline's Lovaza.
Data from: Wikipedia